Pharmala Biotech Holdings Inc. (CSE:MDMA)
Canada · Delayed Price · Currency is CAD 0.1400
0.00 (0.00%)
Jun 30, 2026, 3:41 PM EST
Pharmala Biotech Holdings Market Cap
Pharmala Biotech Holdings has a market cap or net worth of CAD 15.24 million as of July 1, 2026. Its market cap has increased by 37.34% in one year.
Market Cap
15.24M
Enterprise Value
14.67M
Revenue
889.57K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.14
Market Cap Chart
Since January 11, 2022, Pharmala Biotech Holdings's market cap has increased from 6.64M to 15.24M, an increase of 129.59%. That is a compound annual growth rate of 20.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 15.24M | 27.27% |
| Dec 31, 2025 | 11.98M | -53.64% |
| Dec 31, 2024 | 25.84M | 112.35% |
| Dec 29, 2023 | 12.17M | 486.37% |
| Dec 30, 2022 | 2.07M | -68.75% |
| Jan 11, 2022 | 6.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sharp Therapeutics | 30.08M |
| Thiogenesis Therapeutics | 27.99M |
| Devonian Health Group | 25.72M |
| Lobe Sciences | 25.57M |
| Rapid Dose Therapeutics | 12.28M |
| PreveCeutical Medical | 12.24M |
| Britannia Life Sciences | 12.17M |
| Hemostemix | 10.88M |